BDPO Beta Logo
Charts
Backtesting
The Backtester Lab Codeless Libary Editor Documentation
API
Finance
Finance Portfolio Screener Watchlists Economic Calendar Earnings Calendar News Notifications Congress Trading Institutional Investors Insiders
Community
Explore Forum
Market
Marketplace Submit
Profile
Profile Settings
Pricing
More
Terms FAQ Contact Ticker Request Changelog
BDPO Beta Logo
BDPO Beta Logo
Home Charts
Backtesting
The Backtester Lab Codeless Libary Editor Documentation
API
Finance
Finance Portfolio Screener Watchlists Economic Calendar Earnings Calendar News Notifications Congress Trading Institutional Investors Insiders
Community
Explore Forum
Market
Marketplace Submit
Profile
Profile Settings
Pricing
More
Terms FAQ Contact Ticker Request Changelog
GOOG has hit a 52 week high
Google annnouced there quarterly earnings and beating analysts estimates causing the stock to surge to a new 52 week high.
NOC has hit a 52 week high
Northrop Grumman annnouced there quarterly earnings and beating analysts estimates causing the stock to surge to a new 52 week high.
TSLA is down 2%
Tesla is down 2% today after the company annnouced they will be delaying the new model 3.
MSFT has hit a 52 week high
Microsoft annnouced there quarterly earnings and beating analysts estimates causing the stock to surge to a new 52 week high.

Acuta Capital Partners, Llc

13F Holdings
Filed: 2025-02-14
Portfolio Value
99.40M arrow_downward -19.49%
Number of Holdings
lock info
Reporting Date
2024-12-31
Key Stats trending_flat
CIK
0001582844
Filing Date
2025-02-14 00:00:00
Address
255 Shoreline Drive
Redwood City
CA
Prior Value
123.46M
Top 10 Holdings %
lock
Portfolio Value
Acuta Capital Partners, Llc
(13F - 2024-12-31)
Ocular Therapeutix Inc
-
2025-02-14
Value
9.49M
Shares
1.11M
Portfolio %
9.55%
Insmed Inc
-
2025-02-14
Value
7.24M
Shares
104.80K
Portfolio %
7.28%
Tourmaline Bio Inc
-
2025-02-14
Value
7.14M
Shares
351.84K
Portfolio %
7.18%
Crinetics Pharmaceuticals In
-
2025-02-14
Value
6.28M
Shares
122.90K
Portfolio %
6.32%
Enliven Therapeutics Inc
-
2025-02-14
Value
6.02M
Shares
267.37K
Portfolio %
6.05%
Aadi Biosciences Inc
-
2025-02-14
Value
5.83M
Shares
1.85M
Portfolio %
5.87%
Praxis Precision Medicines I
-
2025-02-14
Value
5.19M
Shares
67.50K
Portfolio %
5.23%
Revolution Medicines Inc
-
2025-02-14
Value
4.89M
Shares
111.70K
Portfolio %
4.92%
Argenx Se
-
2025-02-14
Value
4.25M
Shares
6.91K
Portfolio %
4.28%
Vaxcyte Inc
-
2025-02-14
Value
3.68M
Shares
45.00K
Portfolio %
3.71%
Top Increases | Acuta Capital Partners, Llc
(2024-09-30 → 2024-12-31)
Aadi Biosciences Inc
-
2025-02-14
Value Change
arrow_upward 2.03M
Shares
arrow_upward 0.00
Portfolio % Change
arrow_upward 2.78%
Portfolio %
5.87%
Praxis Precision Medicines I
-
2025-02-14
Value Change
arrow_upward 1.89M
Shares
arrow_upward 10.00K
Portfolio % Change
arrow_upward 2.55%
Portfolio %
5.23%
Trevi Therapeutics Inc
-
2025-02-14
Value Change
arrow_upward 2.21M
Shares
arrow_upward 481.46K
Portfolio % Change
arrow_upward 2.41%
Portfolio %
3.20%
Argenx Se
-
2025-02-14
Value Change
arrow_upward 1.05M
Shares
arrow_upward 1.01K
Portfolio % Change
arrow_upward 1.68%
Portfolio %
4.28%
Tectonic Therapeutic Inc
-
2025-02-14
Value Change
arrow_upward 1.11M
Shares
arrow_upward 19.31K
Portfolio % Change
arrow_upward 1.20%
Portfolio %
1.53%
Unicycive Therapeutics Inc
-
2025-02-14
Value Change
arrow_upward 1.02M
Shares
arrow_upward 323.80K
Portfolio % Change
arrow_upward 1.19%
Portfolio %
1.84%
Ocular Therapeutix Inc
-
2025-02-14
Value Change
arrow_upward -865072.00
Shares
arrow_upward -79000.00
Portfolio % Change
arrow_upward 1.16%
Portfolio %
9.55%
Liquidia Corporation
-
2025-02-14
Value Change
arrow_upward 884.46K
Shares
arrow_upward 64.21K
Portfolio % Change
arrow_upward 1.03%
Portfolio %
1.63%
Edgewise Therapeutics Inc
-
2025-02-14
Value Change
arrow_upward 659.00K
Shares
arrow_upward 24.66K
Portfolio % Change
arrow_upward 0.99%
Portfolio %
2.35%
Revolution Medicines Inc
-
2025-02-14
Value Change
arrow_upward -12042.00
Shares
arrow_upward 3.70K
Portfolio % Change
arrow_upward 0.95%
Portfolio %
4.92%
Top Decreases | Acuta Capital Partners, Llc
(2024-09-30 → 2024-12-31)
Enliven Therapeutics Inc
-
2025-02-14
Value Change
arrow_downward -1553459.00
Shares
arrow_downward -29000.00
Portfolio % Change
arrow_downward 0.08%
Portfolio %
6.05%
Artiva Biotherapeutics Inc
-
2025-02-14
Value Change
arrow_downward -236280.00
Shares
arrow_downward 0.00
Portfolio % Change
arrow_downward 0.10%
Portfolio %
0.45%
Mersana Therapeutics Inc
-
2025-02-14
Value Change
arrow_downward -665685.00
Shares
arrow_downward -79500.00
Portfolio % Change
arrow_downward 0.23%
Portfolio %
1.61%
Celcuity Inc
-
2025-02-14
Value Change
arrow_downward -367556.00
Shares
arrow_downward -21600.00
Portfolio % Change
arrow_downward 0.23%
Portfolio %
0.33%
Ultragenyx Pharmaceutical Inc
-
2025-02-14
Value Change
arrow_downward -510835.00
Shares
arrow_downward -4100.00
Portfolio % Change
arrow_downward 0.24%
Portfolio %
0.89%
Gilead Sciences Inc
-
2025-02-14
Value Change
arrow_downward -789694.00
Shares
arrow_downward -10350.00
Portfolio % Change
arrow_downward 0.47%
Portfolio %
0.85%
Terns Pharmaceuticals Inc
-
2025-02-14
Value Change
arrow_downward -1582430.00
Shares
arrow_downward -39500.00
Portfolio % Change
arrow_downward 0.80%
Portfolio %
2.49%
Rocket Pharmaceuticals Inc
-
2025-02-14
Value Change
arrow_downward -1818635.00
Shares
arrow_downward -55500.00
Portfolio % Change
arrow_downward 1.14%
Portfolio %
1.70%
Mereo Biopharma Group Pl-Adr
-
2025-02-14
Value Change
arrow_downward -2453899.00
Shares
arrow_downward -481392.00
Portfolio % Change
arrow_downward 1.45%
Portfolio %
2.74%
Taysha Gene Therapies Inc
-
2025-02-14
Value Change
arrow_downward -2729432.00
Shares
arrow_downward -1234748.00
Portfolio % Change
arrow_downward 1.91%
Portfolio %
1.54%
Acuta Capital Partners, Llc (13F - 2024-12-31) Comparing to 2024-09-30
New/Increased Position added or increased from previous period Closed/Decreased Position closed or decreased from previous period
arrow_upward Increase arrow_downward Decrease
Company Ticker Type Shares Value Current % Previous % % Change $ Change $ Change % Shares Change Status Qtr End Price Filing Date
New Positions | Acuta Capital Partners, Llc
(2024-09-30 → 2024-12-31)
Bright Minds Biosciences Inc
-
2025-02-14
Value
add_circle 2.49M
Shares
69.12K
Portfolio %
2.50%
% Change
2.50%
Cidara Therapeutics Inc
-
2025-02-14
Value
add_circle 1.46M
Shares
54.47K
Portfolio %
1.47%
% Change
1.47%
Newamsterdam Pharma Co Nv
-
2025-02-14
Value
add_circle 1.28M
Shares
50.00K
Portfolio %
1.29%
% Change
1.29%
Zymeworks Inc
-
2025-02-14
Value
add_circle 984.39K
Shares
67.24K
Portfolio %
0.99%
% Change
0.99%
Eledon Pharmaceuticals Inc
-
2025-02-14
Value
add_circle 971.29K
Shares
235.75K
Portfolio %
0.98%
% Change
0.98%
Sangamo Therapeutics Inc
-
2025-02-14
Value
add_circle 754.80K
Shares
740.00K
Portfolio %
0.76%
% Change
0.76%
Forte Biosciences Inc
-
2025-02-14
Value
add_circle 411.94K
Shares
18.14K
Portfolio %
0.41%
% Change
0.41%
Corvus Pharmaceuticals Inc
-
2025-02-14
Value
add_circle 397.54K
Shares
74.31K
Portfolio %
0.40%
% Change
0.40%
Closed Positions | Acuta Capital Partners, Llc
(2024-09-30 → 2024-12-31)
Acelyrin Inc
SLRN
2024-11-14
Value
remove_circle 1.79M
Shares
364.00K
Previous %
0.57%
% Change
-0.57%
Benitec Biopharma Inc
BNTC
2024-11-14
Value
remove_circle 273.86K
Shares
29.80K
Previous %
0.57%
% Change
-0.57%
Climb Bio Inc
-
2024-11-14
Value
remove_circle 274.86K
Shares
54.00K
Previous %
0.57%
% Change
-0.57%
Compass Pathways Plc
CMPS
2024-11-14
Value
remove_circle 2.43M
Shares
386.50K
Previous %
0.57%
% Change
-0.57%
Corbus Pharmaceuticals Holdings
-
2024-11-14
Value
remove_circle 381.65K
Shares
18.50K
Previous %
0.57%
% Change
-0.57%
Dyne Therapeutics Inc
DYN
2024-11-14
Value
remove_circle 1.66M
Shares
46.20K
Previous %
0.57%
% Change
-0.57%
Geron Corp
GERNW
2024-11-14
Value
remove_circle 703.25K
Shares
154.90K
Previous %
0.57%
% Change
-0.57%
Kura Oncology Inc. Common Stock
KURA
2024-11-14
Value
remove_circle 3.85M
Shares
197.00K
Previous %
0.57%
% Change
-0.57%
Leap Therapeutics Inc
LPTX
2024-11-14
Value
remove_circle 309.69K
Shares
120.50K
Previous %
0.57%
% Change
-0.57%
Travere Therapeutics Inc
TVTX
2024-11-14
Value
remove_circle 265.81K
Shares
19.00K
Previous %
0.57%
% Change
-0.57%